Trial Profile
Effect of omalizumab in patients with asthma.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2014
Price :
$35
*
At a glance
- Drugs Omalizumab (Primary)
- Indications Asthma
- Focus Therapeutic Use
- 10 Dec 2014 New trial record